Shanta Bantia
BioCryst Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Biochemical and Molecular Research, Influenza Virus Research Studies, Adenosine and Purinergic Signaling, Cytomegalovirus and herpesvirus research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430(2014)598 cited
- → BCX-1812 (RWJ-270201): Discovery of a Novel, Highly Potent, Orally Active, and Selective Influenza Neuraminidase Inhibitor through Structure-Based Drug Design(2000)377 cited
- → Systematic Structure-Based Design and Stereoselective Synthesis of Novel Multisubstituted Cyclopentane Derivatives with Potent Antiinfluenza Activity(2001)175 cited
- → Anti-influenza virus activity of peramivir in mice with single intramuscular injection(2005)149 cited
- → Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir(2001)148 cited
- → A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)(2005)99 cited
- → BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model(2014)94 cited
- → Design and Synthesis of Benzoic Acid Derivatives as Influenza Neuraminidase Inhibitors Using Structure-Based Drug Design(1997)90 cited
- → Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)—a novel potent and orally active immunosuppressive agent(2001)89 cited
- → Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor—BCX-1777(2003)78 cited